iBio (IBIO) - P/S ratio

P/S ratio as of December 2024 (TTM): 130

According to iBio's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.28. At the end of 2024 the company had a P/S ratio of 103.

P/S ratio history for iBio from 2008 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	103	86.88%
2023	54.9	2455.43%
2022	2.15	-97.59%
2021	89.3	-6.39%
2020	95.4	1124.4%
2019	7.79	-52.51%
2018	16.4	-63.13%
2017	44.5	9.22%
2016	40.7	-9.78%
2015	45.2	27.38%
2014	35.4	1.28%
2013	35.0	31.55%
2012	26.6	6.34%
2011	25.0
2010	N/A	-100%
2009	54.8	2615.61%
2008	2.02

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Genocea Biosciences GNCA	0.0031	-100.00%	🇺🇸 USA
Emergent BioSolutions EBS	0.4011	-99.69%	🇺🇸 USA
Johnson & Johnson JNJ	3.97	-96.94%	🇺🇸 USA
Nektar Therapeutics NKTR	1.84	-98.58%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for iBio (IBIO)

P/S ratio as of December 2024 (TTM): 130